Martha Raymond

Martha Raymond is the Founder/CEO of The Raymond Foundation and also serves as the Founding Executive Director of the GI Cancers Alliance.

For over thirty years, Martha has been a passionate and active advocate for cancer patients and caregivers. She is a frequent speaker and moderator for national oncology conferences and symposiums. Martha also serves as an oncology consultant specializing in program development for clients in academia, pharmaceutical industry and advocacy.

Martha holds advanced graduate certifications in Hospice Care, Palliative Care and Patient Navigation, and has published research in peer-reviewed journals including the Journal of Clinical Oncology and Cancer.

Articles

How Cancer Caregivers Can Stay Connected With Their Loved Ones While Social Distancing

Martha Raymond

May 20th 2020

Caregivers are an essential part of any patient or survivor’s cancer journey and social distancing due to COVID-19 has made the challenges of caregiving even more difficult. However, one expert details how caregivers can still stay connected during the pandemic.

Patients with Cancer Can Teach Others About Resilience in the Face of the COVID-19 Pandemic

Martha Raymond

May 18th 2020

As millions of people face a “new normal” during the COVID-19 pandemic, patients with cancer can teach others about the resilience needed to face the unknown.

Facts Matter for Patients with Cancer During the COVID-19 Pandemic, Says One Advocate

Martha Raymond

May 15th 2020

There's a lot of rapidly changing information on COVID-19 and patients need to take their time and find the facts that matter.

Finding My Greater Purpose Through Patient Advocacy

Martha Raymond

July 30th 2019

Losing both my parents when I was so young led me to what would become my life’s purpose. Advocating for patients with cancer became my motivation and my mission.

Giving a Voice to Patients With GI Cancers

Martha Raymond

January 3rd 2018

Martha Raymond, founder and CEO of the Raymond Foundation, discusses how her organization helps to provide a voice for patients with gastrointestinal (GI) cancers.